Spironolactone and Dysplasia - a phase IV clinical study of FDA data

Summary:

Dysplasia is reported as a side effect among people who take Spironolactone (spironolactone), especially for people who are 60+ old, also take Augmentin, and have Chronic myelomonocytic leukaemia.

The phase IV clinical study analyzes which people have Dysplasia when taking Spironolactone. It is created by eHealthMe based on reports of 119,147 people who have side effects when taking Spironolactone from the FDA, and is updated regularly.

What is Spironolactone?

Spironolactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 122,947 Spironolactone users. Check the latest studies of Spironolactone.

What is Dysplasia?

Dysplasia (enlargement of an organ or tissue) is found to be associated with 242 drugs and 321 conditions by eHealthMe. Check the latest studies of Dysplasia.

On Jul, 16, 2026

119,147 people reported to have side effects when taking Spironolactone.
Among them, 12 people (0.01%) have Dysplasia.

Among these 12 people:

What is the age of people who have Dysplasia when taking Spironolactone? *

What are other drugs people take besides Spironolactone? *

What are other side effects people have besides Dysplasia? *

Abdominal Pain Upper: 6 people, 50.00%
Anaemia (lack of blood): 6 people, 50.00%
Pleural Effusion (water on the lungs): 6 people, 50.00%
Weight Decreased: 5 people, 41.67%
Acute Kidney Failure: 5 people, 41.67%
Nausea And Vomiting: 5 people, 41.67%
Thrombocytopenia (decrease of platelets in blood): 5 people, 41.67%
Dyspnea Exertional: 4 people, 33.33%
Pneumonia: 4 people, 33.33%
Pleurisy (inflammation of the pleurae, which causes pain when breathing): 4 people, 33.33%

What are the existing conditions these people have? *

Hereditary Neuropathic Amyloidosis (hereditary- diseases resulting from abnormal deposition of certain proteins (amyloid) in various bodily areas by problems with signals from the nerves): 2 people, 16.67%
Chronic Myelomonocytic Leukaemia (cancers of the blood-forming cells of the bone marrow): 2 people, 16.67%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 8.33%
Thyroid Diseases: 1 person, 8.33%
Metastases To Bone (cancer spreads to bone): 1 person, 8.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 8.33%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 8.33%
Depression: 1 person, 8.33%
Bowel Movement Irregularity: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Spironolactone and have Dysplasia?

- Check whether Dysplasia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Spironolactone:

Spironolactone (122,947 reports)

Dysplasia treatments and more:

Dysplasia (1,623 reports)

Browse all side effects of Spironolactone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dysplasia:

Dysplasia (242 drugs)

Browse all the conditions that are associated with Dysplasia:

Dysplasia (321 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on spironolactone (the active ingredients of Spironolactone) and Spironolactone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.